These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33569321)

  • 21. Regular aspirin use and lung cancer risk.
    Moysich KB; Menezes RJ; Ronsani A; Swede H; Reid ME; Cummings KM; Falkner KL; Loewen GM; Bepler G
    BMC Cancer; 2002 Nov; 2():31. PubMed ID: 12453317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
    Burn J; Gerdes AM; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans DG; Maher ER; Bertario L; Bisgaard ML; Dunlop MG; Ho JW; Hodgson SV; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar R; Side L; Scott RJ; Thomas HJ; Vasen HF; Barker G; Crawford G; Elliott F; Movahedi M; Pylvanainen K; Wijnen JT; Fodde R; Lynch HT; Mathers JC; Bishop DT;
    Lancet; 2011 Dec; 378(9809):2081-7. PubMed ID: 22036019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.
    Tammemägi MC; Church TR; Hocking WG; Silvestri GA; Kvale PA; Riley TL; Commins J; Berg CD
    PLoS Med; 2014 Dec; 11(12):e1001764. PubMed ID: 25460915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin use and risk of colorectal cancer according to BRAF mutation status.
    Nishihara R; Lochhead P; Kuchiba A; Jung S; Yamauchi M; Liao X; Imamura Y; Qian ZR; Morikawa T; Wang M; Spiegelman D; Cho E; Giovannucci E; Fuchs CS; Chan AT; Ogino S
    JAMA; 2013 Jun; 309(24):2563-71. PubMed ID: 23800934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population-based cohort study.
    Lin CC; Lai MS; Shau WY
    Diabet Med; 2015 Mar; 32(3):324-31. PubMed ID: 25252097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial.
    Cook NR; Lee IM; Zhang SM; Moorthy MV; Buring JE
    Ann Intern Med; 2013 Jul; 159(2):77-85. PubMed ID: 23856681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.
    Rothwell PM; Wilson M; Price JF; Belch JF; Meade TW; Mehta Z
    Lancet; 2012 Apr; 379(9826):1591-601. PubMed ID: 22440947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden.
    Brusselaers N; Lagergren J
    BMJ Open; 2018 Jul; 8(7):e021869. PubMed ID: 29982219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of metformin and aspirin is associated with delayed cancer incidence.
    Sung JJ; Ho JM; Lam AS; Yau ST; Tsoi KK
    Cancer Epidemiol; 2020 Dec; 69():101808. PubMed ID: 32919225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid Cancer and Nonsteroidal Anti-Inflammatory Drug Use: A Pooled Analysis of Patients Older Than 40 Years of Age.
    Patel D; Kitahara CM; Park Y; Liao LM; Linet M; Kebebew E; Nilubol N
    Thyroid; 2015 Dec; 25(12):1355-62. PubMed ID: 26426828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspirin Use and Mortality in Two Contemporary US Cohorts.
    Huang WY; Daugherty SE; Shiels MS; Purdue MP; Freedman ND; Abnet CC; Hollenbeck AR; Hayes RB; Silverman DT; Berndt SI
    Epidemiology; 2018 Jan; 29(1):126-133. PubMed ID: 28863047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006.
    Dhillon PK; Kenfield SA; Stampfer MJ; Giovannucci EL
    Int J Cancer; 2011 May; 128(10):2444-52. PubMed ID: 21128233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Nonadherence to Cancer Screening Examinations With Mortality From Unrelated Causes: A Secondary Analysis of the PLCO Cancer Screening Trial.
    Pierre-Victor D; Pinsky PF
    JAMA Intern Med; 2019 Feb; 179(2):196-203. PubMed ID: 30592477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
    Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
    [No Abstract]   [Full Text] [Related]  

  • 35. Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial.
    Veitonmäki T; Murtola TJ; Talala K; Taari K; Tammela T; Auvinen A
    PLoS One; 2016; 11(4):e0153413. PubMed ID: 27100876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.
    Cook NR; Lee IM; Gaziano JM; Gordon D; Ridker PM; Manson JE; Hennekens CH; Buring JE
    JAMA; 2005 Jul; 294(1):47-55. PubMed ID: 15998890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants.
    Mir MC; Stephenson AJ; Grubb RL; Black A; Kibel AS; Izmirlian G
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2241-9. PubMed ID: 24089460
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.